Fan Q, Li L, Wang T, Emerson R, Xu Y. A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer. Cancers (Basel). 2021;13: pubmed publisher

Giaginis C, Damaskos C, Koutsounas I, Zizi Serbetzoglou A, Tsoukalas N, Patsouris E, et al. Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. BMC Gastroenterol. 2015;15:148 pubmed publisher

Nakashima H, Nguyen T, Goins W, Chiocca E. Interferon-stimulated gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1/p62. J Biol Chem. 2015;290:1485-95 pubmed publisher

Lyu J, Li Z, Roberts J, Qi Y, Xiong J. The short-chain fatty acid acetate coordinates with CD30 to modulate T-cell survival. Mol Biol Cell. 2023;34:br11 pubmed publisher

Chu S, Moujaber O, Lemay S, Stochaj U. Multiple pathways promote microtubule stabilization in senescent intestinal epithelial cells. NPJ Aging. 2022;8:16 pubmed publisher

Govindarajalu G, Selvam M, Palchamy E, Baluchamy S. N-terminal truncations of human bHLH transcription factor Twist1 leads to the formation of aggresomes. Mol Cell Biochem. 2018;439:75-85 pubmed publisher

Chuang M, Wu S, Tang S, Lai X, Lai H, Hsu K, et al. The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation. PLoS ONE. 2013;8:e73401 pubmed publisher

Giaginis C, Alexandrou P, Delladetsima I, Giannopoulou I, Patsouris E, Theocharis S. Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions. Tumour Biol. 2014;35:61-71 pubmed publisher

Sukhdeo K, Mani M, Hideshima T, Takada K, Pena Cruz V, Mendez G, et al. ?-catenin is dynamically stored and cleared in multiple myeloma by the proteasome-aggresome-autophagosome-lysosome pathway. Leukemia. 2012;26:1116-9 pubmed publisher